rs2229426
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004104.5(FASN):c.5336C>T(p.Pro1779Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0103 in 1,612,814 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0086 ( 9 hom., cov: 34)
Exomes 𝑓: 0.010 ( 79 hom. )
Consequence
FASN
NM_004104.5 missense
NM_004104.5 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 4.31
Genes affected
FASN (HGNC:3594): (fatty acid synthase) The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008900583).
BP6
Variant 17-82083522-G-A is Benign according to our data. Variant chr17-82083522-G-A is described in ClinVar as [Benign]. Clinvar id is 462068.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82083522-G-A is described in Lovd as [Likely_benign]. Variant chr17-82083522-G-A is described in Lovd as [Benign].
BS2
High AC in GnomAd4 at 1314 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASN | ENST00000306749.4 | c.5336C>T | p.Pro1779Leu | missense_variant | 31/43 | 1 | NM_004104.5 | ENSP00000304592.2 | ||
FASN | ENST00000634990.1 | c.5330C>T | p.Pro1777Leu | missense_variant | 31/43 | 5 | ENSP00000488964.1 |
Frequencies
GnomAD3 genomes AF: 0.00862 AC: 1313AN: 152262Hom.: 9 Cov.: 34
GnomAD3 genomes
AF:
AC:
1313
AN:
152262
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00856 AC: 2136AN: 249424Hom.: 18 AF XY: 0.00853 AC XY: 1155AN XY: 135466
GnomAD3 exomes
AF:
AC:
2136
AN:
249424
Hom.:
AF XY:
AC XY:
1155
AN XY:
135466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0105 AC: 15309AN: 1460434Hom.: 79 Cov.: 37 AF XY: 0.0102 AC XY: 7418AN XY: 726514
GnomAD4 exome
AF:
AC:
15309
AN:
1460434
Hom.:
Cov.:
37
AF XY:
AC XY:
7418
AN XY:
726514
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00862 AC: 1314AN: 152380Hom.: 9 Cov.: 34 AF XY: 0.00876 AC XY: 653AN XY: 74518
GnomAD4 genome
AF:
AC:
1314
AN:
152380
Hom.:
Cov.:
34
AF XY:
AC XY:
653
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
48
ALSPAC
AF:
AC:
45
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
92
ExAC
AF:
AC:
970
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | FASN: BP4, BS1, BS2 - |
Epileptic encephalopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 02, 2025 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.
REVEL
Benign
Sift
Benign
D;.
Sift4G
Uncertain
D;D
Polyphen
B;.
Vest4
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at